Impact of Adding Integrated Neuromuscular Inhibition Technique to Mulligan Therapy in Symptomatic Forward Head Posture

ConditionForward Head Posture

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18-35

SponsorCairo University

About this trial

this study will be conducted to investigate the impact of adding integrated neuromuscular inhibition technique to mulligan therapy in symptomatic forward head posture.

Eligibility criteria

Qualifiers

CVA equal or less than 50

Had cervical pain for more than three months and had visited an orthopedist clinic

Disqualifiers

cervical spine spondylosis

fractures or cervical spinal surgery

Cervical or shoulder neurological movement disorder.

Temporo-mandibular surgery, (5) Pathologic trauma

Trial design

Treatments tested in this trial

Integrated Neuromuscular Inhibition Technique and mulligan therapy
Integrated Neuromuscular Inhibition Technique
mulligan therapy
postural correction exercises

Treatment groups

120 Participants

are divided into 4 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Cairo University

Lead sponsor

Source ClinicalTrials.gov